TITLE

DISTRIBUTION OF COLORECTAL CANCERS AND ADENOMAS IN A SCREENED POPULATION

AUTHOR(S)
Macafee, D.A.L.; Scholefield, J.H.; Whynes, D.K.
PUB. DATE
April 2003
SOURCE
Gut;Apr2003 Supplement 1, Vol. 52, pA28
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The Nottingham trial of Faecal occult blood (FOBT) screening, randomised 152 850 individuals between the ages of 45 and 74, with the identification of 1551 cancers and 1497 individuals with at least one adenoma, within the screened group. The distribution of colorectal cancers was 37% (576) in the rectum, 31% (484) in the left colon and 32% (491) proximal to or including the splenic flexure (right-sided lesions). Rectal cancers among males remained high (43%) compared with females (29%), while 39% (261) of female cancers were right-sided. Of those who had adenomas detected by colonoscopy, 80% (1201) had only one adenoma. Considering only the distribution of the index polyp of each individual, 91% (1358) were found distal to the splenic flexure. This is the first time a screening study has identified a right-sided shift in colorectal cancer distribution. This trend has been noted by other recent papers but not within a screening programme. This shift has important implications for any screening modality if a national screening programme is to be considered.
ACCESSION #
9747449

 

Related Articles

  • Comparison of a guaiac based and an immunochemical faecal occult blood test in screening for colorectal cancer in a general average risk population. Guittet, I.; Bouvier, V.; Mariotte, N.; Vallee, J. P.; Arsène, D.; Boufreux, S.; Tichet, J.; Launoy, G. // Gut;Feb2007, Vol. 56 Issue 2, p210 

    Background: The guaiac faecal occult blood test (G-FOBT) is recommended as a screening test for colorectal cancer but its low sensitivity has prevented its use throughout the world. Methods: We compared the performances of the reference G-FOBT (non-rehydrated Hemoccult II test) and the...

  • Sensitivity of Immunochemical Fecal Occult Blood Test to Small Colorectal Adenomas. Morikawa, Tamiya; Kato, Jun; Yamaji, Yutaka; Wada, Ryoichi; Mitsushima, Toru; Sakaguchi, Kohsaku; Shiratori, Yasushi // American Journal of Gastroenterology;Oct2007, Vol. 102 Issue 10, p2259 

    BACKGROUND: Although the immunochemical fecal occult blood test (FOBT) is reportedly more sensitive to large adenomas or colorectal cancer (CRC) than the guaiac-based FOBT, the sensitivity of the immunochemical FOBT to small adenomas has scarcely been reported. Previous reports have indicated...

  • Diagnostic accuracy of immunochemical versus guaiac faecal occult blood tests for colorectal cancer screening. Parra-Blanco, Adolfo; Gimeno-García, Antonio; Quintero, Enrique; Nicolás, David; Moreno, Santiago; Jiménez, Alejandro; Hernández-Guerra, Manuel; Carrillo-Palau, Marta; Eishi, Yoshinobu; López-Bastida, Julio // Journal of Gastroenterology;Jul2010, Vol. 45 Issue 7, p703 

    Immunochemical tests show important advantages over chemical-based faecal occult blood tests (FOBT) for colorectal cancer (CRC) screening, but comparison studies are limited. This study was performed to compare the accuracy of a sensitive immunochemical test with the guaiac test for detecting...

  • Prospective evaluation of methylated SEPT9 in plasma for detection of asymptomatic colorectal cancer. Church, Timothy Robert; Wandell, Michael; Lofton-Day, Catherine; Mongin, Steven J.; Burger, Matthias; Payne, Shannon R.; Castaños-Vélez, Esmeralda; Blumenstein, Brent A.; Rösch, Thomas; Osborn, Neal; Snover, Dale; Day, Robert W.; Ransohoff, David F. // Gut;Feb2014, Vol. 63 Issue 2, p317 

    Background As screening methods for colorectal cancer (CRC) are limited by uptake and adherence, further options are sought. A blood test might increase both, but none has yet been tested in a screening setting. Objective We prospectively assessed the accuracy of circulating methylated SEPT9 DNA...

  • Population-based screening for colorectal cancer with faecal occult blood test-do we really have enough evidence? Ekelund, Göran; Manjer, Jonas; Zackrisson, Sophia // International Journal of Colorectal Disease;Nov2010, Vol. 25 Issue 11, p1269 

    Introduction: Population-based randomised controlled trials (RCT) have shown that invitation to biennial screening with faecal occult blood testing (FOBT) during 10 or more years reduced colorectal cancer-specific mortality. These results have stimulated plans to introduce mass screening in...

  • Liver adenomas and carcinomas: correlations and relationship to body weight in long-term rodent cancer bioassays. Gray, G.M.; Linkov, I.; Polkanov, M.; Wilson, R. // Toxicology & Industrial Health;2000, Vol. 16 Issue 6, p211 

    The most common cancers induced in laboratory rodents are liver cancers — both adenomas and carcinomas. There has been a long argument about the relative merits of combining them or considering them separately in the interpretation of long-term bioassays for chemical carcinogenesis. In...

  • New Test for Ovarian Cancer.  // Medical Update;Feb2002, Vol. 27 Issue 8, p6 

    Reports on a study conducted by the U.S. National Cancer Institute that examined the use of an experimental blood test in the early detection of ovarian cancer.

  • Ovarian cancer: The silent killer. Newton, Sue // Total Health;Feb93, Vol. 15 Issue 1, p51 

    Reports on ovarian cancer and the blood test called CU-125. Risk factors; Contemporary Oncology, report source.

  • Research Brief: Blood and cancer risk.  // GP: General Practitioner;2/25/2011, p10 

    The article reports that researchers in the U.S. have found that blood test are useful to find markers of bladder cancer risk.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics